Business

Edwards Lifesciences stock price target raised to $89 at RBC on growth outlook


Edwards Stay Cescis shares raised to $ 89 in RBC to development expectations

2025-07-26 07:39:00

Related Articles

Boeing settles with Canadian man whose family died in 737 MAX crash

2 weeks ago

There’s a ‘scary’ recession warning in the too-good-to-be-true data

6 days ago

Eventual, climate fintech, raises $7.5 million seed round from AlleyCorp and Upfront Ventures

4 days ago

Amazon Ring’s founder is back as CEO with a hard pivot to AI. How Jamie Siminoff went from ‘Shark Tank’ reject to $1 billion brand

1 week ago